These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22462058)

  • 21. Anti-inflammatory effect of Inonotus obliquus, Polygala senega L., and Viburnum trilobum in a cell screening assay.
    Van Q; Nayak BN; Reimer M; Jones PJ; Fulcher RG; Rempel CB
    J Ethnopharmacol; 2009 Sep; 125(3):487-93. PubMed ID: 19577624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production.
    Zheng W; Miao K; Liu Y; Zhao Y; Zhang M; Pan S; Dai Y
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1237-54. PubMed ID: 20532760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic hepatitis C virus infection: genotyping and its clinical role.
    Bowden DS; Berzsenyi MD
    Future Microbiol; 2006 Jun; 1(1):103-12. PubMed ID: 17661689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study of the antiherpetic activity of the chaga mushroom (Inonotus obliquus) extracts in the Vero cells infected with the herpes simplex virus].
    Polkovnikova MV; Nosik NN; Garaev TM; Kondrashina NG; Finogenova MP; Shibnev VA
    Vopr Virusol; 2014; 59(2):45-8. PubMed ID: 25069286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Selection of direct-acting antiviral agents for chronic hepatitis C infection].
    He YJ; Liu ZH; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):169-172. PubMed ID: 29804388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative Analysis of Different Inonotus obliquus].
    Guo XF; Piao ZY; Wang SM
    Zhong Yao Cai; 2015 Apr; 38(4):669-73. PubMed ID: 26672329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
    Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
    Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
    Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
    Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant effect of Inonotus obliquus.
    Cui Y; Kim DS; Park KC
    J Ethnopharmacol; 2005 Jan; 96(1-2):79-85. PubMed ID: 15588653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C.
    Wilson EM; Rosenthal ES; Kattakuzhy S; Tang L; Kottilil S
    Clin Microbiol Rev; 2017 Jan; 30(1):23-42. PubMed ID: 27795306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure.
    Colpitts CC; Baumert TF
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27537906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
    Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
    Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural characterization of bioactive heteropolysaccharides from the medicinal fungus Inonotus obliquus (Chaga).
    Wold CW; Kjeldsen C; Corthay A; Rise F; Christensen BE; Duus JØ; Inngjerdingen KT
    Carbohydr Polym; 2018 Apr; 185():27-40. PubMed ID: 29421057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
    Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
    J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.
    Apriyanto DR; Aoki C; Hartati S; Hanafi M; Kardono LB; Arsianti A; Louisa M; Sudiro TM; Dewi BE; Sudarmono P; Soebandrio A; Hotta H
    Jpn J Infect Dis; 2016 May; 69(3):213-20. PubMed ID: 26255732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
    Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
    Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of hepatitis C virus infection by polyoxometalates.
    Qi Y; Xiang Y; Wang J; Qi Y; Li J; Niu J; Zhong J
    Antiviral Res; 2013 Nov; 100(2):392-8. PubMed ID: 24025401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
    Galani BR; Sahuc ME; Sass G; Njayou FN; Loscher C; Mkounga P; Deloison G; Brodin P; Rouillé Y; Tiegs G; Séron K; Moundipa PF
    Arch Virol; 2016 May; 161(5):1169-81. PubMed ID: 26843184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct-acting antiviral agents for the treatment of HCV.
    Thompson AJ; Locarnini S
    Antivir Ther; 2012; 17(6 Pt B):1105-7. PubMed ID: 23188736
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antiviral activity of sulfated polysaccharide from the brown algae Laminaria japonica against avian influenza A (H5N1) virus infection in the cultured cells].
    Makarenkova ID; Deriabin PG; L'vov DK; Zviagintseva TN; Besednova NN
    Vopr Virusol; 2010; 55(1):41-5. PubMed ID: 20364671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.